Terlipressin vs. Somatostatin in bleeding esophageal varices: A controlled, double‐blind study
Siegfried Walker, Heinz‐Peter Kreichgauer, J. Christian Bode – 1 June 1992 – Fifty episodes of bleeding from esophageal or gastric varices in 33 patients with cirrhosis were randomized to treatment with either intravenous terlipressin (2 mg initially and 1 mg every 4 hr for 24 hr together with bolus injection and continuous infusion of placebo) or with somatostatin (250 μg as a bolus and continuous infusion of 250 μg/hr somatostatin for 24 hr and placebo injections). Standard therapy with transfusions, fluid and electrolyte correction and lactulose was administered in both groups.